Down-regulation of gp130 in nasopharyngeal carcinoma

Yong-Song Lin, Li Ching Lin, Mei Hui Huang, Ai Ju Huang, Yu Tzu Huang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: The purpose of this study was to explore the expression and biological functions of glycoprotein 130 (gp130) in Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC). A prospective study was performed. Methods: Ten patients with NPC and 10 patients with nasopharyngeal lymphoid hyperplasia (LH) were enrolled in this study. The transcripts of IL-27 receptors (gp130 and WSX-1) in the biopsy specimens derived from NPC were compared with that from LH by using reverse-transcription polymerase chain reaction. Cell lines including EBV -, Burkitt-like lymphoma (BJAB) cells, human adult peripheral blood mononuclear cells, and lymphoblastoid cell lines were used to provide evidence of the biological function of gp130. In addition, killing assay for natural killer (NK) cells was performed in the presence of gp130. Results: There was significantly stronger expression of gp130 on the LH specimens than on the NPC specimens. The levels of gp130 mRNA were reduced in the EBV-transformed cells. The cytotoxicity ratio against gp130-deficient B cells was diminished compared with gp130-existent B cells. Conclusion: The expression of gp130 is down-regulated in patients with NPC. We presume that EBV controls the functions of NK cells through regulation of gp130 cytokine receptor.

Original languageEnglish
Pages (from-to)28-32
Number of pages5
JournalAmerican Journal of Rhinology and Allergy
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Glycoproteins
Down-Regulation
Human Herpesvirus 4
Hyperplasia
Natural Killer Cells
B-Lymphocytes
Interleukin-27
Nasopharyngeal carcinoma
Cell Line
Cytokine Receptors
Burkitt Lymphoma
Reverse Transcription
Blood Cells
Prospective Studies
Biopsy
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Epstein-Barr virus
  • Gp130
  • Interleukin-12 (IL-12)
  • Interleukin-27 (IL-27)
  • Nasopharyngeal carcinoma
  • Natural killer cells
  • Tumor surveillance

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Immunology and Allergy

Cite this

Lin, Y-S., Lin, L. C., Huang, M. H., Huang, A. J., & Huang, Y. T. (2009). Down-regulation of gp130 in nasopharyngeal carcinoma. American Journal of Rhinology and Allergy, 23(1), 28-32. https://doi.org/10.2500/ajra.2009.23.3257

Down-regulation of gp130 in nasopharyngeal carcinoma. / Lin, Yong-Song; Lin, Li Ching; Huang, Mei Hui; Huang, Ai Ju; Huang, Yu Tzu.

In: American Journal of Rhinology and Allergy, Vol. 23, No. 1, 01.2009, p. 28-32.

Research output: Contribution to journalArticle

Lin, Y-S, Lin, LC, Huang, MH, Huang, AJ & Huang, YT 2009, 'Down-regulation of gp130 in nasopharyngeal carcinoma', American Journal of Rhinology and Allergy, vol. 23, no. 1, pp. 28-32. https://doi.org/10.2500/ajra.2009.23.3257
Lin, Yong-Song ; Lin, Li Ching ; Huang, Mei Hui ; Huang, Ai Ju ; Huang, Yu Tzu. / Down-regulation of gp130 in nasopharyngeal carcinoma. In: American Journal of Rhinology and Allergy. 2009 ; Vol. 23, No. 1. pp. 28-32.
@article{e17a41d1d3404fa2af28753d9ef31e08,
title = "Down-regulation of gp130 in nasopharyngeal carcinoma",
abstract = "Background: The purpose of this study was to explore the expression and biological functions of glycoprotein 130 (gp130) in Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC). A prospective study was performed. Methods: Ten patients with NPC and 10 patients with nasopharyngeal lymphoid hyperplasia (LH) were enrolled in this study. The transcripts of IL-27 receptors (gp130 and WSX-1) in the biopsy specimens derived from NPC were compared with that from LH by using reverse-transcription polymerase chain reaction. Cell lines including EBV -, Burkitt-like lymphoma (BJAB) cells, human adult peripheral blood mononuclear cells, and lymphoblastoid cell lines were used to provide evidence of the biological function of gp130. In addition, killing assay for natural killer (NK) cells was performed in the presence of gp130. Results: There was significantly stronger expression of gp130 on the LH specimens than on the NPC specimens. The levels of gp130 mRNA were reduced in the EBV-transformed cells. The cytotoxicity ratio against gp130-deficient B cells was diminished compared with gp130-existent B cells. Conclusion: The expression of gp130 is down-regulated in patients with NPC. We presume that EBV controls the functions of NK cells through regulation of gp130 cytokine receptor.",
keywords = "Epstein-Barr virus, Gp130, Interleukin-12 (IL-12), Interleukin-27 (IL-27), Nasopharyngeal carcinoma, Natural killer cells, Tumor surveillance",
author = "Yong-Song Lin and Lin, {Li Ching} and Huang, {Mei Hui} and Huang, {Ai Ju} and Huang, {Yu Tzu}",
year = "2009",
month = "1",
doi = "10.2500/ajra.2009.23.3257",
language = "English",
volume = "23",
pages = "28--32",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Down-regulation of gp130 in nasopharyngeal carcinoma

AU - Lin, Yong-Song

AU - Lin, Li Ching

AU - Huang, Mei Hui

AU - Huang, Ai Ju

AU - Huang, Yu Tzu

PY - 2009/1

Y1 - 2009/1

N2 - Background: The purpose of this study was to explore the expression and biological functions of glycoprotein 130 (gp130) in Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC). A prospective study was performed. Methods: Ten patients with NPC and 10 patients with nasopharyngeal lymphoid hyperplasia (LH) were enrolled in this study. The transcripts of IL-27 receptors (gp130 and WSX-1) in the biopsy specimens derived from NPC were compared with that from LH by using reverse-transcription polymerase chain reaction. Cell lines including EBV -, Burkitt-like lymphoma (BJAB) cells, human adult peripheral blood mononuclear cells, and lymphoblastoid cell lines were used to provide evidence of the biological function of gp130. In addition, killing assay for natural killer (NK) cells was performed in the presence of gp130. Results: There was significantly stronger expression of gp130 on the LH specimens than on the NPC specimens. The levels of gp130 mRNA were reduced in the EBV-transformed cells. The cytotoxicity ratio against gp130-deficient B cells was diminished compared with gp130-existent B cells. Conclusion: The expression of gp130 is down-regulated in patients with NPC. We presume that EBV controls the functions of NK cells through regulation of gp130 cytokine receptor.

AB - Background: The purpose of this study was to explore the expression and biological functions of glycoprotein 130 (gp130) in Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC). A prospective study was performed. Methods: Ten patients with NPC and 10 patients with nasopharyngeal lymphoid hyperplasia (LH) were enrolled in this study. The transcripts of IL-27 receptors (gp130 and WSX-1) in the biopsy specimens derived from NPC were compared with that from LH by using reverse-transcription polymerase chain reaction. Cell lines including EBV -, Burkitt-like lymphoma (BJAB) cells, human adult peripheral blood mononuclear cells, and lymphoblastoid cell lines were used to provide evidence of the biological function of gp130. In addition, killing assay for natural killer (NK) cells was performed in the presence of gp130. Results: There was significantly stronger expression of gp130 on the LH specimens than on the NPC specimens. The levels of gp130 mRNA were reduced in the EBV-transformed cells. The cytotoxicity ratio against gp130-deficient B cells was diminished compared with gp130-existent B cells. Conclusion: The expression of gp130 is down-regulated in patients with NPC. We presume that EBV controls the functions of NK cells through regulation of gp130 cytokine receptor.

KW - Epstein-Barr virus

KW - Gp130

KW - Interleukin-12 (IL-12)

KW - Interleukin-27 (IL-27)

KW - Nasopharyngeal carcinoma

KW - Natural killer cells

KW - Tumor surveillance

UR - http://www.scopus.com/inward/record.url?scp=70149121670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70149121670&partnerID=8YFLogxK

U2 - 10.2500/ajra.2009.23.3257

DO - 10.2500/ajra.2009.23.3257

M3 - Article

C2 - 19379608

AN - SCOPUS:70149121670

VL - 23

SP - 28

EP - 32

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 1

ER -